EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Fenugreek derived diosgenin as an emerging source for diabetic therapy

Yamini Tak, Manpreet Kaur, Abhishek Chitranashi, Mahesh Kumar Samota, Preeti Verma, Manoj Bali, Chiranjeev Kumawat

Frontiers in Nutrition · 02.02.2024 · 11

DOI: 10.3389/fnut.2024.1280100 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Nutrition, online erschienen am 02.02.2024. Verfasst von Yamini Tak und 6 weiteren Autor:innen. Beteiligte Einrichtung: Agricultural Research Station, Agriculture University, Kota, India. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetes is a chronic metabolic disease that endangers the entire body’s tissues and organs. Diabetes impairs glucose and insulin regulation in the human body by causing pancreatic cell damage. Diabetes modifies pathways such as serine/threonine protein kinase (Akt) and Protein kinase C (PKC)/- glucose transporter 4 (GLUT4), peroxisome proliferator-activated receptor (PPAR) glucose absorption, and inhibits α-amylase and α-glucosidase, Sodium/glucose cotransporter 1 (SGLT-1), and Na + -K + -ATPase activity. Diabetes may also be caused by a decrease in the expression of sterol regulatory element binding protein 1 (SREBP-1) and its target genes, fatty acid synthase (FAS), stearoyl-CoA desaturase-1 (SCD-1), and acetyl-CoA carboxylase α (ACC), as well as a decrease in the levels of C/EBP homologous protein (CHOP), Caspase12, and Caspase3 proteins. Diabetes has long been linked to diseases of the cardiovascular, nervous, skeletal, reproductive, hepatic, ocular, and renal systems. Diosgenin, a steroidal compound derived from fenugreek, aids in the prevention of diabetes by altering cellular pathways in favor of healthy bodily functions. Diosgenin is a new nutraceutical on the market that claims to cure diabetes in particular. This article focuses on diosgenin extraction and purification, fenugreek bioactive compounds, pharmacological properties of diosgenin, mode of action of diosgenin to cure diabetes, and dosages.

Schlagwörter

Stichwörter der Autor:innen

bioactivediabetesdiosgeninextractionfenugreek

Autor:innen und Institutionen

  • Agricultural Research Station, Agriculture University, Kota, India.
  • Department of Biochemistry, Punjab Agricultural University, Ludhiana, India.
  • Division of Biochemistry, ICAR-Indian Agricultural Research Institute, New Delhi, India.
  • ICAR-Central Institute of Post-Harvest Engineering & Technology, Ludhiana, India.
  • School of Sciences, Rayat Bahra University, Mohali, India.
  • Sri Karan Narendra Agriculture University, Jaipur, India.

Zitieren

APA

Tak, Y., Kaur, M., Chitranashi, A., Samota, M. K., Verma, P., Bali, M., & Kumawat, C. (2024). Fenugreek derived diosgenin as an emerging source for diabetic therapy. Frontiers in Nutrition, 11. https://doi.org/10.3389/fnut.2024.1280100

Vancouver

Tak Y, Kaur M, Chitranashi A, Samota MK, Verma P, Bali M, et al. Fenugreek derived diosgenin as an emerging source for diabetic therapy. Frontiers in Nutrition. 2024;11. doi:10.3389/fnut.2024.1280100

BibTeX
@article{Tak2024,
  author = {Tak, Yamini and Kaur, Manpreet and Chitranashi, Abhishek and Samota, Mahesh Kumar and Verma, Preeti and Bali, Manoj and Kumawat, Chiranjeev},
  title = {Fenugreek derived diosgenin as an emerging source for diabetic therapy},
  journal = {Frontiers in Nutrition},
  year = {2024},
  volume = {11},
  doi = {10.3389/fnut.2024.1280100}
}
Kostenlos starten →